about
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsSystematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.Prediction of structural stability of short beta-hairpin peptides by molecular dynamics and knowledge-based potentials.Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides.Novel synthesis of various orthogonally protected Cα-methyllysine analogues and biological evaluation of a vapreotide analogue containing (S)-α-methyllysine.Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach.Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analoguesAnticonvulsant neuropeptides as drug leads for neurological diseases.Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.Production of peptides as generic drugs: a patent landscape of octreotide.Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.Gastrin, somatostatin, G and D cells of gastric ulcer in rats.Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.Efficient siRNA-peptide conjugation for specific targeted delivery into tumor cells.Somatostatin receptor-targeted organometallic iridium(iii) complexes as novel theranostic agents.Molecular Modeling Suggests Conformational Scaffolds Specifically Targeting Five Subtypes of Somatostatin Receptors
P2860
Q24564195-E6EC0298-9A2D-44CB-B640-1225B0850D5CQ31108159-9068F478-52B5-4FF2-94C3-C03768FD008AQ33338632-FE61E05F-A4AA-4CF5-BD3D-EAD7264101D2Q34227953-58E26F86-FD16-4CF2-B137-24803DF27674Q34940355-75750970-EADB-4417-8159-5943FFA6CB51Q36459128-0D2E998D-F7C6-4650-9110-03909A5AFEA0Q37426662-D731B693-8AEA-41BA-800B-53FB01F8FFA7Q37845684-90D0032F-577D-4AD0-BC16-11B265D227D8Q38302368-2DC8C7D8-B8F1-46FB-9641-1DE62564D977Q38754043-640880EB-968D-4576-9D04-0AED2CF0E4F7Q40635613-32ADB030-2C11-4FE2-A23F-4C314123FEB5Q42270329-6609FE51-2691-4A26-9875-F53AB7222DE4Q42666778-01C33B94-FE68-4886-84F7-4C1B8C074B28Q48218817-23239DE6-1B41-4709-9054-B7698D08753AQ52662227-02235133-1551-4394-9A6A-D22B544516C5Q57273387-8ECCAEC6-B88E-45D7-8983-A583A6D3C6BB
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Somatostatin analogs.
@ast
Somatostatin analogs.
@en
Somatostatin analogs.
@nl
type
label
Somatostatin analogs.
@ast
Somatostatin analogs.
@en
Somatostatin analogs.
@nl
prefLabel
Somatostatin analogs.
@ast
Somatostatin analogs.
@en
Somatostatin analogs.
@nl
P2093
P1476
Somatostatin analogs.
@en
P2093
P304
P356
10.1034/J.1399-3011.2001.00873.X
P577
2001-08-01T00:00:00Z